VOYA Investment Management
GLUE icon

VOYA Investment Management’s Monte Rosa Therapeutics GLUE Stock Holding History

VOYA Investment Management’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Buy
82,339
+55,957
+212% +$1.07M ﹤0.01% 1351
2025
Q4 		$414K Buy
+26,382
New +$356K ﹤0.01% 1839
2025
Q3 		– Sell
-12,958
Closed -$58.4K – 2527
2025
Q2 		$58.4K Buy
12,958
+1,345
+12% +$6K ﹤0.01% 2575
2025
Q1 		$53.9K Sell
11,613
-552
-5% -$3.38K ﹤0.01% 2535
2024
Q4 		$84.4K Sell
12,165
-957
-7% -$7.18K ﹤0.01% 2610
2024
Q3 		$69.5K Buy
13,122
+1,969
+18% +$9.94K ﹤0.01% 2728
2024
Q2 		$41.7K Buy
11,153
+595
+6% +$3.03K ﹤0.01% 2803
2024
Q1 		$74.4K Sell
10,558
-1,907
-15% -$11.3K ﹤0.01% 2677
2023
Q4 		$70.4K Sell
12,465
-80,365
-87% -$315K ﹤0.01% 2817
2023
Q3 		$445K Hold
92,830
– – ﹤0.01% 2100
2023
Q2 		$636K Buy
92,830
+502
+0.5% +$3.25K ﹤0.01% 1945
2023
Q1 		$719K Hold
92,328
– – ﹤0.01% 1836
2022
Q4 		$703K Sell
92,328
-6,874
-7% -$57.3K ﹤0.01% 1832
2022
Q3 		$810K Buy
99,202
+88,772
+851% +$815K ﹤0.01% 1742
2022
Q2 		$101K Buy
+10,430
New +$105K ﹤0.01% 2615
2022
Q1 		– Sell
-95,355
Closed -$1.95M – 2694
2021
Q4 		$1.95M Sell
95,355
-7,466
-7% -$156K ﹤0.01% 1165
2021
Q3 		$2.29M Sell
102,821
-1,356
-1% -$38.9K ﹤0.01% 1113
2021
Q2 		$2.36M Buy
+104,177
New +$2.12M ﹤0.01% 1130

Other funds holding GLUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

VOYA Investment Management's GLUE Position: Q1 2026 in Review

VOYA Investment Management increased its Monte Rosa Therapeutics (GLUE) stake by 212% in Q1 2026, buying an estimated $1.07M and bringing the position to 82,339 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

VOYA Investment Management first reported a position in GLUE in Q2 2021 and has held it in 18 quarters since. The position peaked at $2.36M in Q2 2021. 190 funds tracked by Wall St. Rank hold GLUE as of Q1 2026.

  • VOYA Investment Management held 82,339 shares of Monte Rosa Therapeutics worth $1.35M as of Q1 2026.
  • VOYA Investment Management bought 55,957 Monte Rosa Therapeutics shares in Q1 2026, an estimated $1.07M.
  • Monte Rosa Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1351 holding.
  • VOYA Investment Management first reported a position in Monte Rosa Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • VOYA Investment Management's Monte Rosa Therapeutics position peaked at $2.36M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.